To include your compound in the COVID-19 Resource Center, submit it here.

Panzem NCD 2-methoxyestradiol: Development discontinued

EntreMed reported in its earnings that in March it discontinued development of

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE